Skip to main content
Journal of Ginseng Research logoLink to Journal of Ginseng Research
. 2014 May 27;38(3):194–202. doi: 10.1016/j.jgr.2014.05.002

Complete 1H-NMR and 13C-NMR spectral analysis of the pairs of 20(S) and 20(R) ginsenosides

Heejung Yang 1, Jeom Yong Kim 2, Sun Ok Kim 2, Young Hyo Yoo 2, Sang Hyun Sung 3,
PMCID: PMC4213847  PMID: 25378994

Abstract

Background

Ginsenosides, the major ingredients of Panax ginseng, have been studied for many decades in Asian countries as a result of their wide range of pharmacological properties. The less polar ginsenosides, with one or two sugar residues, are not present in nature and are produced during manufacturing processes by methods such as heating, steaming, acid hydrolysis, and enzyme reactions. 1H-NMR and 13C-NMR spectroscopic data for the identification of the less polar ginsenosides are often unavailable or incomplete.

Methods

We isolated 21 compounds, including 10 pairs of 20(S) and 20(R) less polar ginsenosides (1–20), and an oleanane-type triterpene (21) from a processed ginseng preparation and obtained complete 1H-NMR and 13C-NMR spectroscopic data for the following compounds, referred to as compounds 121 for rapid identification: 20(S)-ginsenosides Rh2 (1), 20(R)-Rh2 (2), 20(S)-Rg3 (3), 20(R)-Rg3 (4), 6′-O-acetyl-20(S)-Rh2 [20(S)-AcetylRh2] (5), 20(R)-AcetylRh2 (6), 25-hydroxy-20(S)-Rh2 (7), 25-hydroxy-20(S)-Rh2 (8), 20(S)-Rh1 (9), 20(R)-Rh1 (10), 20(S)-Rg2 (11), 20(R)-Rg2 (12), 25-hydroxy-20(S)-Rh1 (13), 25-hydroxy-20(R)-Rh1 (14), 20(S)-AcetylRg2 (15), 20(R)-AcetylRg2 (16), Rh4 (17), Rg5 (18), Rk1 (19), 25-hydroxy-Rh4 (20), and oleanolic acid 28-O-β-D-glucopyranoside (21).

Keywords: less polar ginsenosides, nuclear magnetic resonance spectroscopy, Panax ginseng, protopanaxadiol, protopanaxatriol

1. Introduction

Ginsenosides, major components in Panax ginseng Meyer, are mainly classified into two groups of the dammarane-type triterpenes: protopanaxadiol (PPD) and protopanaxatriol (PPT) [1]. The substitution of sugar chains at C-3 or C-20 in PPD, or at C-3, C-6, and C-20 in PPT gives rise to a wide range of ginsenosides [2]. The PPD type typically includes the ginsenosides Rb1, Rb2, Rc, and Rd, whereas the PPT type includes Re, Rf, Rg1, and Rg2, which have three to five sugar moieties, in harvested ginseng. During processing by steaming with heat and acidic solutions, or in microbial reactions, these polar ginsenosides decrease and the less polar ginsenosides, such as Rg2, Rg3, Rh1, and Rh2, increase [3–5]. It has been suggested that they could be generated by the elimination of sugar chains or by dehydroxylation [6]. These reactions can also generate the irregular Δ20(21) and Δ20(22) ginsenosides, such as Rg5, Rh3, Rh4, and Rk1, which are rarely found in nature [7]. In particular, the 20(R)-ginsenosides, including 20(R)-Rh2 and 20(R)-Rg3, are derived by selective deglycosylation and dehydroxylation at C-20, followed by biotransformation by reaction with a hydroxyl group [8,9]. The acetylated ginsenosides are generated by decarboxylation from the malonylated ginsenosides, including malonyl (Mal)-Rb1, Rb2, Rc, Rd, and Re [10]. As the less polar ginsenosides can be easily absorbed into blood vessels and act as the pharmacological agents with potential as drug candidates, the mass production or isolation of the less polar ginsenosides is of much interest in the ginseng industry [5].

Recent improvements in chromatographic techniques have led to the analysis and isolation of the stereoisomers of minor ginsenosides in ginseng preparations [11]. The structure–activity relationships between the diverse ginsenosides isolated by these improved techniques has been studied in both cancer cells and noncancer cells [12].

In this study, we isolated 21 minor ginsenosides from a processed ginseng preparation and unequivocally determined their structures by one-dimensional and two-dimensional NMR spectroscopy and compared these results with previously published data. The NMR data obtained for these minor ginsenosides will be useful in studying the structure–activity relationships between structural modifications such as the number of sugar groups, the sugar linkage at C-6, the number of hydroxyl groups, and the stereoisomers of 20(S) and 20(R), as well as in the identification of stereoisomers of ginsenosides.

2. Materials and methods

2.1. General procedure

Column chromatography (CC) was carried out using Kiesgel 60 silica gel (40–60 μm, 230–400 mesh, Merck, USA), YMC-GEL ODS-A (5–150 μm, YMC), and Sephadex LH-20 (25–100μM, Pharmacia, NJ, USA) columns. Thin-layer chromatography was carried out using Kiesgel 60 F254 coated normal silica gel and RP-18 F254 coated reversed-phase (RP) silica gel columns. The 1H-NMR and 13C-NMR, 1H-1H COSY, HSQC, and HMBC spectra were recorded on a Bruker AMX 500 or 600 spectrometer in pyridine-d5. The solvent signals were used as internal standards. The high-performance liquid chromatography (HPLC) system consisted of a G-321 pump (Gilson, USA), a G-151 UV detector (Gilson), and a YMC-Pack Pro C18 column (250 mm × 10 mm i.d.; 5 μm); and all chromatograms were monitored at 210 nm. HPLC-grade solvents (Fisher Scientific, USA) were used in the MeOH–H2O or MeCN–H2O system.

2.2. Ginseng preparation

The processed ginseng preparation was gifted from Greencrosshs (Sungnam, Korea). It was prepared using patented technology and a previously reported method [13]. Briefly, the harvested ginseng was repeatedly extracted with ethanol, followed by reaction with an enzyme containing ginsenoside-β-glucosidase. After acid hydrolysis of the residue, the reactant was purified with HP-20 resin followed by washing out with distilled water and, finally, 95% ethanol.

2.3. Isolation of ginsenosides from the processed ginseng preparation

Powders of the processed ginseng extract (GE) (90 g) were each subjected to normal silica CC (20 × 5 cm column) with a gradient elution of solvents (CHCl3:MeOH = 10:1, 7:1, 5:1, 3:1, 0:1; all 1-L volumes) and 24 sub-fractions (GE1–24) were obtained. 20(S/R)-AcetylRh2 (5, 6) (20 mg, Rt = 14.1 min) were obtained from the GE-5 (2.8 g) sub-fraction by RP silica gel CC (20 × 5 cm; MeOH:H2O = 9:1, 1 L), followed by preparative HPLC (MeOH:H2O = 65:35, 4 mL/min). Oleanolic acid 28-O-β-D-glucopyranose (21) (200 mg) was isolated by recrystallization (100% MeOH) from the sub-fraction separated from the GE-7 (6.5 g) sub-fraction by RP silica gel CC (10 × 3 cm; MeOH:H2O = 7:3, 2 L). Five sub-fractions (GE8–10 A–E) were obtained from GE8–10 (12.1 g) by RP silica gel CC (MeOH:H2O = 8.5:1.5, 4 L). Rh4 (17) (5 mg, Rt = 19.1 min) was isolated from GE8–10 B, and 20(S)-Rh2 (1) (300 mg, Rt = 5.7 min) and 20(R)-Rh2 (2) (210 mg, Rt = 6.1 min) were isolated from GE8–10 C by preparative HPLC (MeCN:H2O = 55:45, 13 mL/min). The mixtures of 25-hydroxy-Rh4 (20) (35 mg, Rt = 11.1 min), 20S/R-Rh1 (9, 10) (90 mg, Rt = 13.2 min), 25-hydroxy-20(S)-Rh2 (7) (28 mg, Rt = 23.1 min), and 25-hydroxy-20(R)-Rh2 (8) (100 mg, Rt = 23.3 min) were prepared from GE12–14 (8.2 g) and were isolated by RP silica gel CC (10 × 3 cm; MeOH:H2O = 7:3, 4 L) followed by preparative HPLC (MeCN:H2O = 50:50, 70:30, 13 mL/min). GE15–18 (10.1 g) were subjected to RP silica gel CC (MeOH:H2O = 6:4, 4 L) to give five sub-fractions (GE15–18 A–E). 20S-AcetylRg2 (15) (15 mg, Rt = 24.7 min) and 20R-AcetylRg2 (16) (8 mg, Rt = 25.1 min) were isolated from GE15–18 B. Rk1 (19) (25 mg, Rt = 19.9 min) and Rg5 (18) (31 mg, Rt = 20.3 min) were obtained from GE15–18 D by preparative HPLC (MeOH:H2O = 7:3, 10 mL/min), respectively. 20(S/R)-Rg2 (11, 12) (50 mg), 20(S)-Rg3 (3) (400 mg), and 20(R)-Rg3 (4) (400 mg) were obtained from GE19–20 (8.1 g) sub-fractions by RP silica gel CC (10 × 3 cm) with a mixture of MeOH:H2O (3:1, 5 L). 20(S)-Rg2 (11) (10 mg, Rt = 13.1 min) and 20(R)-Rg2 (12) (15 mg, Rt = 13.4 min) were purified using preparative HPLC (MeCN:H2O = 35:65, 10 mL/min). GE21–22 (3.1 g) sub-fractions were further isolated to give the mixture of 25-hydroxy-20(S/R)-Rh1 (13, 14) (30 mg).

3. Results and discussion

The structures of compounds 1–21 were unequivocally determined by comparing the one-dimensional and two-dimensional NMR spectrometry and mass spectrometry data with previously published values. These were: 20(S)-ginsenosides Rh2 (1) [14], 20(R)-Rh2 (2) [15], 20(S)-Rg3 (3) [16], 20(R)-Rg3 (4) [16], 6′-O-acetyl-20(S)-Rh2 (20(S)-AcetylRh2) (5) [16], 20(R)-AcetylRh2 (6) and 25-hydroxy-20(S)-Rh2 (7) [13], 25-hydroxy-20(R)-Rh2 (8) [13], 20(S)-Rh1 (9) [17], 20(R)-Rh1 (10) [17], 20(S)-Rg2 (11) [17], 20(R)-Rg2 (12) [18], 25-hydroxy-20(S)-Rh1 (13) [19], 25-hydroxy-20(R)-Rh1 (14) [19], 20(S)-AcetylRg2 (15) [20], 20(R)-AcetylRg2 (16) [20], Rk1 (17) [21], Rh4 (18) [17], 25-hydroxy-Rh4 (19) [18], Rg5 (20) [21], and oleanolic acid 28-O-β-D-glucopyranoside (21) [22] (Fig. 1). Of these compounds, compound 6 had not been reported previously. Compounds 5 and 6, and 13 and 14 were isolated as mixtures of the stereoisomers and were not purified to individual stereoisomers. Compounds 121 were categorized by their backbones (PPD type 16; PPD-derived type, 7, 8, 18, and 19; PPT type, 912, 15, and 16; PPT-derived type, 13, 14, and 17; and an oleanane-type triterpene, 21). The 1H-NMR and 13C-NMR spectral data are given in Tables 1–6.

Fig. 1.

Fig. 1

Structures of compounds 121 isolated from the processed ginseng extract. Glu, β-D-Glucose; AcetylGlu, β-D-6′-O-Acetyl-glucose; Rha, α-L-Rhamnose.

Table 1.

1H-NMR Spectroscopic Data for Compounds 1–8 in Pyridine-d5

No. 20(S)-Rh21) (1) 20(R)-Rh21) (2) 20(S)-Rg32) (3) 20(R)-Rg32) (4) 20(S/R)-AcetylRh2 2),3) (5 and 6) 25-Hydroxy-20(S)-Rh22) (7) 25-Hydroxy-20(R)-Rh22) (8)
δH (J in Hz)
1a 1.49 (1H, m) 1.49 (1H, m) 1.46 (1H, m) 1.47 (1H, m) 1.58 (1H, m) 1.49 (1H, m) 1.49 (1H, m)
1b 0.79 (1H, m) 0.79 (1H, m) 0.72 (1H, m) 0.72 (1H, m) 0.88 (1H, m) 0.75 (1H, m) 0.75 (1H, m)
2a 2.19 (1H, m) 2.20 (1H, m) 2.16 (1H, m) 2.17 (1H, m) 2.12 (1H, m) 2.20 (1H, m) 2.18 (1H, m)
2b 1.78 (1H, m) 1.79 (1H, m) 1.79 (1H, m) 1.81 (1H, m) 1.78 (1H, m) 1.38 (1H, m) 1.36 (1H, m)
3 3.35 (1H, dd, J = 4.6, 11.9) 3.36 (1H, dd, J = 3.7, 11.5) 3.26 (1H, dd, J = 11.75, 4.35) 3.26 (1H, dd, J = 11.75, 4.35) 3.24 (1H, m) 3.36 (1H, dd, J = 4.4, 11.7) 3.35 (1H, dd, J = 4.4, 11.7)
5 0.72 (1H, d, J = 11.9) 0.73 (1H, d, J = 11.5) 0.65 (1H, d, J = 11.4) 0.66 (1H, d, J = 11.5) 0.71 (1H, m) 0.73 (1H, m) 0.71 (1H, m)
6a 1.48 (2H, m) 1.50 (2H, m) 1.49 (1H, m) 1.52 (1H, m) 1.48 (2H, m) 1.58-1.32 (2H, m) 1.52-1.36 (2H, m)
6b 1.35 (1H, m) 1.40 (1H, m)
7a 1.47 (1H, m) 1.49 (1H, m) 1.42 (1H, m) 1.41 (1H, m) 1.45 (1H, m) 1.47 (1H, m) 1.48 (1H, m)
7b 1.21 (1H, m) 1.23 (1H, m) 1.19 (1H, m) 1.21 (1H, m) 1.20 (1H, m) 1.22 (1H, m) 1.22 (1H, m)
9 1.40 (1H, m) 1.42 (1H, m) 1.37 (1H, m) 1.37 (1H, m) 1.41 (1H, m) 1.41 (1H, m) 1.41 (1H, m)
11a 1.58 (1H, m) 1.58 (1H, m) 2.02 (1H, m) 2.00 (1H, m) 1.52 (1H, m) 2.05 (1H, m) 2.03 (1H, m)
11b 1.11 (1H, m) 1.13 (1H, m) 1.55 (1H, m) 1.55 (1H, m) 1.02 (1H, m) 1.54 (1H, m) 1.52 (1H, m)
12 3.89 (1H, m) 3.91 (1H, m) 3.90 (1H, m) 3.91 (1H, m) 3.82 (1H, m) 3.90 (1H, m) 3.90 (1H, m)
13 2.01 (1H, m) 2.00 (1H, m) 2.00 (1H, m) 1.97 (1H, m) 1.94 (1H, m) 2.06 (1H, m) 2.00 (1H, m)
15a 2.01 (1H, m) 2.11 (1H, m) 1.50 (1H, m) 1.56 (1H, m) 1.96 (1H, m) 1.58 (1H, m) 1.57 (1H, m)
15b 1.49 (1H, m) 1.51 (1H, m) 1.05 (1H, m) 1.04 (1H, m) 1.42 (1H, m) 1.02 (1H, m) 1.02 (1H, m)
16a 1.88 (1H, m) 1.91 (1H, m) 1.87 (1H, m) 1.93 (1H, m) 1.84 (1H, m) 1.92 (1H, m) 1.91 (1H, m)
16b 1.39 (1H, m) 1.35 (1H, m) 1.38 (1H, m) 1.35 (1H, m) 1.44 (1H, m) 1.81 (1H, m) 1.80 (1H, m)
17 2.35 (1H, m) 2.38 (1H, m) 2.33 (1H, m) 2.38 (1H, m) 2.26 (1H, m) 2.30 (1H, m) 2.34 (1H, m) 2.40 (1H, m)
18 0.77 (3H, s) 0.80 (3H, s) 0.94 (3H, s) 0.99 (3H, s) 0.94 (3H, s) 0.91 (3H, s) 0.80 (3H, s) 0.81 (3H, s)
19 0.94 (3H, s) 1.00 (3H, s) 0.77 (3H, s) 0.80 (3H, s) 0.78 (3H, s) 1.01 (3H, s) 1.00 (3H, s)
21 1.40 (3H, s) 1.38 (3H, s) 1.40 (3H, s) 1.37 (3H, s) 1.32 (3H, s) 1.41 (3H, s) 1.38 (3H, s)
22a 2.01 (1H, m) 1.70 (2H, m) 2.01 (1H, m) 1.71 (2H, m) 1.90 (1H, m) 1.62 (2H, m) 2.00 (1H, m) 1.71 (2H, m)
22b 1.68 (1H, m) 1.68 (1H, m) 1.58 (1H, m) 1.63 (1H, m)
23a 2.57 (1H, m) 2.52 (1H, m) 2.58 (1H, m) 2.52 (1H, m) 2.46 (1H, m) 2.48 (1H, m) 2.16 (1H, m) 2.10 (2H, m)
23b 2.29 (1H, m) 2.45 (1H, m) 2.26 (1H, m) 2.47 (1H, m) 2.16 (1H, m) 2.42 (1H, m) 1.82 (1H, m) 1.98 (1H, m)
24 5.29 (1H, t-like) 5.30 (1H, t-like) 5.28 (1H, t, J = 6.95) 5.30 (1H, t-like) 5.24 (1H, m) 5.25 (1H, m) 1.71 (2H, m) 1.71 (2H, m)
26 1.63 (3H, s) 1.68 (3H, s) 1.60 (3H, s) 1.68 (3H, s) 1.62 (3H, s) 1.37 (3H, s) 1.40 (3H, s)
27 1.60 (3H, s) 1.63 (3H, s) 1.60 (3H, s) 1.64 (3H, s) 1.55 (3H, s) 1.38 (3H, s) 1.40 (3H, s)
28 1.30 (3H, s) 1.30 (3H, s) 1.27 (3H, s) 1.27 (3H, s) 1.20 (3H, s) 1.30 (3H, s) 1.30 (3H, s)
29 0.97 (3H, s) 0.98 (3H, s) 1.08 (3H, s) 1.09 (3H, s) 0.88 (3H, s) 0.98 (3H, s) 0.98 (3H, s)
30 0.94 (3H, s) 0.98 (3H, s) 0.92 (3H, s) 0.96 (3H, s) 0.96 (3H, s) 0.94 (3H, s) 0.94 (3H, s)
3-O-β-D-Glucopyranosyl
1′ 4.92 (1H, d, J = 7.8) 4.92 (1H, d, J = 7.60) 4.90 (1H, d, J = 7.55) 4.91 (1H, d, J = 7.6) 4.74 (1H, m) 4.93 (1H, d, J = 7.8) 4.91 (1H, d, J = 7.8)
2′ 4.02 (1H, m) 4.02 (1H, m) 4.23 (1H, m) 4.22 (1H, m) 3.92 (1H, m) 4.02 (1H, m) 4.01 (1H, m)
3′ 4.23 (1H, t, J = 8.7) 4.22 (1H, m) 4.21 (1H, m) 4.20 (1H, m) 4.06 (1H, m) 4.25 (1H, m) 4.22 (1H, t, J = 8.8)
4′ 4.18 (1H, t, J = 8.7) 4.18 (1H, m) 4.11 (1H, m) 4.13 (1H, m) 3.88 (1H, m) 4.20 (1H, m) 4.18 (1H, t, J = 8.8)
5′ 3.90 (1H, m) 3.98 (1H, m) 3.88 (1H, m) 3.89 (1H, m) 3.87 (1H, m) 3.99 (1H, m) 3.98 (1H, m)
6′a 4.56 (1H, d, J = 11.9) 4.57 (1H, d, J = 11.9) 4.53 (1H, m) 4.54 (1H, m) 4.79 (1H, m) 4.57 (1H, dd, J = 2.2, 11.7) 4.56 (1H, dd, J = 1.9, 11.7)
6′b 3.67 (1H, dd, J = 5.5, 11.9) 4.37 (1H, dd, J = 5.5, 11.9) 4.33 (1H, m) 4.32 (1H, m) 4.67 (1H, dd, J = 6.42, 11.88) 4.37 (1H, dd, J = 5.4, 11.7) 4.37 (1H, dd, J = 5.4, 11.7)
2′-O-β-D-Glucopyranosyl
1′′ 5.35 (1H, d, J = 7.65) 5.36 (1H, d, J = 7.65)
2′′ 4.10 (1H, m) 4.12 (1H, m)
3′′ 4.29 (1H, m) 4.28 (1H, m)
4′′ 4.32 (1H, m) 4.31 (1H, m)
5′′ 3.91 (1H, m) 3.93 (1H, m)
6′′a 4.46 (1H, m) 4.46 (1H, m)
6′′b 4.45 (1H, m) 4.45 (1H, m)
COCH3 1.93 (3H, s)
1)

1H-NMR data measured at 600 MHz

2)

1H-NMR data measured at 500 MHz

3)

20(S/R)-AcetylRh2; 6′-O-acetyl-20(S/R)-Rh2

Table 2.

13C-NMR Spectroscopic Data for Compounds 1–8 in Pyridine-d5

No. 20(S)-Rh21) (1) 20(R)-Rh21) (2) 20(S)-Rg32) (3) 20(R)-Rg32) (4) 20(S/R)-AcetylRh22),3) (5 and 6) 25-Hydroxy-20(S)-Rh22) (7) 25-Hydroxy-20(R)-Rh22) (8)
δC multiplicity
1 39.1 t 39.1 t 39.1 t 39.1 t 38.9 t 39.1 t 39.1 t
2 26.7 t 26.6 t 26.7 t 26.6 t 26.6 t 26.7 t 26.7 t
3 88.7 d 88.7 d 88.9 d 88.9 d 89.0 d 88.8 d 88.7 d
4 39.6 s 39.6 s 39.6 s 39.6 s 39.4 s 39.7 s 39.6 s
5 56.3 d 56.3 d 56.3 d 56.3 d 56.2 d 56.1 d 56.4 d 56.3 d
6 18.4 t 18.4 t 18.4 t 18.4 t 18.2 t 18.4 t 18.4 t
7 35.1 t 35.1 t 35.1 t 35.1 t 34.9 t 35.2 t 35.1 t
8 40.0 s 40.0 s 39.9 s 40.0 s 39.8 s 40.0 s 40.0 s
9 50.3 d 50.3 d 50.3 d 50.3 d 50.2 d 50.4 d 50.3 d
10 36.9 s 36.9 s 36.8 s 36.9 s 36.8 s 37.0 s 36.9 s
11 31.3 t 31.4 t 31.3 t 31.4 t 31.1 t 31.2 t 32.1 t 32.1 t
12 70.9 d 70.8 d 70.9 d 70.8 d 70.7 d 70.6 d 71.0 d 70.8 d
13 48.5 d 49.2 d 48.5 d 49.2 d 48.9 d 48.2 d 48.6 d 49.2 d
14 51.7 s 51.7 s 51.6 s 51.7 s 51.5 s 51.7 s 51.7 s
15 32.0 t 32.1 t 32.0 t 32.1 t 31.7 t 31.8 t 31.4 t 31.4 t
16 26.8 t 26.7 t 26.8 t 26.7 t 26.4 t 27.2 t 26.6 t
17 54.7 d 50.6 d 54.7 d 50.6 d 54.5 d 50.3 d 54.7 d 50.7 d
18 16.3 q 16.3 q 15.8 q 15.8 q 15.6 q 16.8 q 16.7 q
19 15.8 q 15.8 q 16.3 q 16.3 q 16.1 q 15.8 q 15.8 q
20 72.9 s 72.9 s 72.9 s 72.9 s 72.8 s 73.3 s 73.3 s
21 27.0 q 22.7 q 27.0 q 22.7 q 26.7 q 22.4 q 26.9 q 22.8 q
22 35.8 t 43.2 t 35.8 t 43.2 t 35.6 t 42.9 t 36.5 t 44.0 t
23 22.9 t 22.6 t 23.0 t 22.5 t 22.3 t 22.7 t 19.1 t 18.7 t
24 126.3 d 126 d 126.2 d 126.0 d 126.0 d 125.8 d 45.7 t 45.5 t
25 130.7 s 130.7 s 130.7 s 130.7 s 130.5 s 69.6 s 69.7 s
26 25.8 q 25.8 q 25.7 q 25.8 q 25.7 q 25.6 q 30.2 q 30.1 q
27 17.6 q 17.7 q 17.0 q 17.2 q 17.1 q 16.8 q 29.9 q 29.9 q
28 28.1 q 28.1 q 28.1 q 28.1 q 27.9 q 28.1 q 28.1 q
29 16.7 q 16.7 q 16.5 q 16.5 q 16.5 q 16.4 q 16.3 q
30 17.0 q 17.3 q 17.6 q 17.6 q 17.5 q 17.0 q 17.3 q
3-O-β-D-Glucopyranosyl
1′ 106.9 d 106.9 d 105.0 d 105.1 d 106.6 d 106.9 d 106.9 d
2′ 75.7 d 75.7 d 83.4 d 83.4 d 74.5 d 75.8 d 75.7 d
3′ 78.7 d 78.7 d 77.9 d 77.9 d 78.1 d 78.7 d 78.7 d
4′ 71.8 d 71.8 d 71.6 d 71.6 d 71.3 d 71.9 d 71.8 d
5′ 78.3 d 78.3 d 78.2 d 78.2 d 75.1 d 78.3 d 78.3 d
6′ 63.0 t 63.0 t 62.8 t 62.8 t 64.4 t 63.1 t 63.0 t
2′-O-β-D-Glucopyranosyl
1′′ 106.0 d 106.0 d
2′′ 77.1 d 77.1 d
3′′ 78.3 d 78.3 d
4′′ 71.6 d 71.6 d
5′′ 78.0 d 78.1 d
6′′ 62.7 t 62.7 t
COCH3 170.5 s
COCH3 20.6 q

Multiplicity of 13C-NMR data was determined by DEPT experiments

1)

13C-NMR data measured at 150 MHz

2)

13C-NMR data measured at 125 MHz

3)

20(S/R)-AcetylRh2; 6′-O-acetyl-20(S/R)-Rh2

Table 3.

1H-NMR Spectroscopic Data for Compounds 9–16 in Pyridine-d5

No. 20(S)-Rh11) (9) 20(R)-Rh11) (10) 20(S)-Rg21) (11) 20(R)-Rg22) (12) 25-Hydroxy-20(S/R)-Rh1 1) (13 and 14) 20(S)-Acetyl-Rg21),3) (15) 20(R)-Acetyl-Rg21),4) (16)
δH (J in Hz)
1a 1.66 (1H, m) 1.69 (1H, m) 1.61 (1H, m) 1.61 (1H, m) 1.67 (1H, m) 1.65 (1H, m) 1.64 (1H, m)
1b 1.02 (1H, m) 1.01 (1H, m) 0.92 (1H, m) 0.92 (1H, m) 1.02 (1H, m) 0.98 (1H, m) 0.97 (1H, m)
2a 1.89 (1H, m) 1.90 (1H, m) 1.83 (1H, m) 1.82 (1H, m) 1.89 (1H, m) 1.82 (1H, m) 1.82 (1H, m)
2b 1.80 (1H, m) 1.80 (1H, m) 1.76 (1H, m) 1.76 (1H, m) 1.82 (1H, m) 1.76 (1H, m) 1.76 (1H, m)
3 3.50 (1H, m) 3.50 (1H, br d) 3.43 (1H, m) 3.35 (1H, br s) 3.50 (1H, m) 3.46 (1H, m) 3.46 (1H, dd, J = 4.1, 11.2)
5 1.40 (1H, m) 1.42 (1H, d, J = 10.5) 1.37 (1H, m) 1.39 (1H, m) 1.42 (1H, m) 1.37 (1H, m) 1.39 (1H, m)
6 4.40 (1H, td, J = 2.8, 10.5 ) 4.43 (1H, td, J = 2.9, 10.5 ) 4.64 (1H, m) 4.68 (1H, m) 4.42 (1H, m) 4.75 (1H, s) 4.70 (1H, td, J = 3.3, 10.6)
7a 2.50 (1H, m) 2.51 (1H, m) 2.22 (1H, m) 2.23 (1H, m) 2.51 (1H, m) 2.14 (1H, m) 2.15 (1H, m)
7b 1.91 (1H, m) 1.93 (1H, m) 1.95 (1H, m) 1.96 (1H, m) 1.93 (1H, m) 1.97 (1H, m) 1.98 (1H, m)
9 1.53 (1H, m) 1.57 (1H, m) 1.51 (1H, m) 1.52 (1H, m) 1.58 (1H, m) 1.55 (1H, s) 1.56 (1H, s)
11a 2.11 (1H, m) 2.13 (1H, m) 2.04 (1H, m) 2.09 (1H, m) 2.13 (1H, m) 2.14 (1H, m) 2.15 (1H, m)
11b 1.56 (1H, m) 1.52 (1H, m) 1.51 (1H, m) 1.54 (1H, m) 1.56 (1H, m) 1.56 (1H, m) 1.57 (1H, m)
12 3.88 (1H, m) 3.91 (1H, m) 3.89 (1H, m) 3.90 (1H, m) 3.89 (1H, m) 3.93 (1H, m) 3.95 (1H, m)
13 2.01 (1H, m) 2.00 (1H, m) 1.97 (1H, m) 1.96 (1H, m) 2.02 (1H, m) 2.04 (1H, m) 2.01 (1H, m)
15a 1.59 (1H, m) 1.59 (1H, m) 1.51 (1H, m) 1.50 (1H, m) 1.63 (1H, m) 1.62 (1H, m) 1.62 (1H, m)
15b 1.07 (1H, m) 1.11 (1H, m) 0.83 (1H, m) 0.91 (1H, m) 1.10 (1H, m) 0.98 (1H, m) 1.02 (1H, m)
16a 1.76 (1H, m) 1.80 (1H, m) 1.73 (1H, m) 1.82 (1H, m) 1.32 (2H, m) 1.82 (1H, m) 1.88 (1H, m)
16b 1.30 (1H, m) 1.28 (1H, m) 1.28 (1H, m) 1.22 (1H, m) 1.38 (1H, m) 1.30 (1H, m)
17 2.26 (1H, m) 2.32 (1H, m) 2.25 (1H, m) 2.34 (1H, m) 2.28 (1H, m) 2.35 (1H, m) 2.31 (1H, m) 2.37 (1H, m)
18 1.16 (3H, s) 1.22 (3H, s) 1.18 (3H, s) 1.22 (3H, s) 1.03 (3H, s) 1.22 (3H, s) 1.25 (3H, s)
19 1.00 (3H, s) 1.04 (3H, s) 0.93 (3H, s) 0.96 (3H, s) 1.25 (3H, s) 0.99 (3H, s) 1.02 (3H, s)
21 1.37 (3H, s) 1.37 (3H, s) 1.38 (3H, s) 1.36 (3H, s) 1.38 (3H, s) 1.35 (3H, m) 1.35 (3H, s)
22a 2.01 (1H, m) 1.68 (2H, m) 1.98 (1H, m) 2.01 (1H, m) 2.00 (1H, m) 1.67 (2H, m) 2.04 (1H, m) 1.68 (2H, m)
22b 1.66 (1H, m) 1.62 (1H, m) 1.68 (1H, m) 1.63 (1H, m) 1.67 (1H, m)
23a 2.56 (1H, m) 2.48 (1H, m) 2.58 (1H, m) 2.57 (1H, m) 2.13 (1H, m) 2.02-1.99 (2H, m) 2.57 (1H, m) 2.49 (1H, m)
23b 2.25 (1H, m) 2.41 (1H, m) 2.23 (1H, m) 2.29 (1H, m) 1.86 (1H, m) 2.25 (1H, m) 2.41 (1H, m)
24 5.30 (1H, t-like) 5.28 (1H, t-like) 5.31 (1H, t-like) 5.29 (1H, t-like) 1.70 (2H, t-like) 5.29 (1H, t-like) 5.28 (1H, t-like)
26 1.63 (3H, s) 1.67 (3H, s) 1.63 (3H, s) 1.67 (3H, s) 1.38 (3H, s) 1.62 (3H, s) 1.68 (3H, m)
27 1.60 (3H, s) 1.61 (3H, s) 1.60 (3H, s) 1.62 (3H, s) 1.40 (3H, s) 1.59 (3H, s) 1.60 (3H, s)
28 2.05 (3H, s) 2.06 (3H, s) 2.06 (3H, s) 2.09 (3H, s) 2.05 (3H, s) 2.05 (3H, m) 2.03 (3H, m)
29 1.57 (3H, s) 1.59 (3H, s) 1.31 (3H, s) 1.34 (3H, s) 1.58 (3H, s) 1.29 (3H, s) 1.28 (3H, s)
30 0.79 (3H, s) 0.84 (3H, s) 0.91 (3H, s) 0.95 (3H, s) 0.82 (3H, s) 0.97 (3H, s) 1.00 (3H, s)
6-O-β-D-glucopyranosyl
1′ 5.00 (1H, m) 5.03 (1H, m) 5.23 (1H, d, J = 6.9) 5.26 (1H, m) 5.02 (1H, m) 5.22 (1H, d, J = 7.0) 5.22 (1H, d, J = 7.0)
2′ 4.08 (1H, m) 4.09 (1H, m) 4.32 (1H, m) 4.32 (1H, m) 4.07 (1H, m) 4.33 (1H, m) 4.32 (1H, m)
3′ 4.23 (1H, m) 4.25 (1H, m) 4.33 (1H, m) 4.36 (1H, m) 4.23 (1H, m) 4.29 (1H, m) 4.29 (1H, m)
4′ 4.19 (1H, m) 4.20 (1H, m) 4.19 (1H, m) 4.19 (1H, m) 4.07 (1H, m) 3.92 (1H, m) 3.94 (1H, m)
5′ 3.92 (1H, m) 3.95 (1H, m) 3.93 (1H, m) 3.95 (1H, m) 3.94 (1H, m) 4.01 (1H, t-like) 4.03 (1H, t-like, J = 8.2)
6′a 4.51 (1H, m) 4.52 (1H, dd, J = 1.9, 11.4) 4.49 (1H, m) 4.50 (1H, m) 4.51 (1H, m) 5.00 (1H, m) 4.90 (1H, m)
6′b 4.34 (1H, m) 4.35 (1H, dd, J = 5.3, 11.4) 4.36 (1H, m) 4.37 (1H, m) 4.34 (1H, m) 4.61 (1H, m) 4.63 (1H, m)
2′-O-α-L-rhamnopyranosyl
1′ 6.47 (1H, br s) 6.47 (1H, s) 6.47 (1H, s) 6.47 (1H, s)
2′′ 4.75 (1H, m) 4.78 (1H, m) 4.68 (1H, dt, J = 3.2, 10.6) 4.75 (1H, m)
3′′ 4.63 (1H, m) 4.66 (1H, m) 4.64 (1H, m) 4.64 (1H, m)
4′′ 4.30 (1H, m) 4.31 (1H, m) 4.34 (1H, m) 4.33 (1H, m)
5′′ 4.92 (1H, m) 4.94 (1H, m) 4.98 (1H, m) 4.80 (1H, m)
6′′ 1.76 (3H, d, J = 6.2) 1.78 (3H, br s) 1.76 (3H, d, J = 6.2) 1.77 (3H, d, J = 6.1)
COCH3 2.04 (3H, s) 2.08 (3H, s)
1)

1H-NMR data measured at 500 MHz

2)

1H-NMR data measured at 600 MHz

3)

20(S)-AcetylRg2; 6′-O-acetyl-20(S)-Rg2

4)

20(R)-AcetylRg2; 6′-O-acetyl-20(R)-Rg2

Table 4.

13C-NMR Spectroscopic Data for Compounds 9–16 in Pyridine-d5

No. 20(S)-Rh11) (9) 20(R)-Rh11) (10) 20(S)-Rg21) (11) 20(R)-Rg22) (12) 25-Hydroxy-20(S/R)-Rh11) (13 and 14) 20(S)-Acetyl-Rg21),3) (15) 20(R)-Acetyl-Rg21),4) (16)
δC multiplicity
1a 39.3 t 39.3 t 39.5 t 39.6 t 39.6 t 39.5 t 39.5 t
2 27.8 t 27.9 t 27.7 t 27.7 t 27.9 t 27.6 t 27.6 t
3 78.5 d 78.5 d 78.3 d 78.3 d 78.5 d 78.2 d 78.1 d
4 40.3 s 40.3 s 41.1 s 39.9 s 40.3 s 39.8 s 39.8 s
5 61.4 d 61.4 d 60.7 d 60.8 d 61.4 d 60.5 d 60.5 d
6 80.0 d 80.0 d 74.2 d 74.3 d 80.0 d 72.2 d 73.3 d
7 45.2 t 45.1 t 46.0 t 46.0 t 45.2 t 45.1 t 46.1 t 46.1 t
8 41.0 s 41.1 s 41.1 s 41.1 s 41.0 s 39.2 s 39.2 s
9 50.1 d 50.1 d 49.7 d 49.7 d 50.2 d 49.6 d 49.6 d
10 39.6 s 39.6 s 39.9 s 39.9 s 39.3 s 41.1 s 41.1 s
11 32.0 t 32.2 t 32.0 t 32.1 t 32.1 t 32.0 t 32.0 t
12 71.0 d 70.9 d 71.0 d 70.9 d 71.0 d 70.9 d 70.8 d
13 48.2 d 48.8 d 48.1 d 48.8 d 48.2 d 48.9 d 48.2 d 48.8 d
14 51.6 s 51.7 s 51.6 s 51.7 s 51.6 s 51.6 s 51.6 s
15 31.2 t 31.3 t 31.2 t 31.3 t 31.3 t 31.2 t 31.3 t
16 26.7 t 26.6 t 26.8 t 26.6 t 26.8 t 26.7 t 26.5 t
17 54.7 d 50.5 d 54.6 d 50.5 d 54.6 d 50.7 d 54.7 d 50.4 d
18 17.3 q 17.3 q 17.6 q 17.6 q 17.6 q 17.0 q 17.1 q
19 17.6 q 17.6 q 17.5 q 17.5 q 17.3 q 17.5 q 17.4 q
20 72.9 s 73.0 s 72.9 s 72.9 s 73.3 s 72.9 s 72.9 s
21 26.9 q 22.7 q 27.0 q 22.7 q 27.1 q 22.7 q 26.9 q 22.6 q
22 35.8 t 43.2 t 35.7 t 43.2 t 36.4 t 43.9 t 35.8 t 43.1 t
23 22.9 t 22.5 t 22.9 t 22.5 t 19.1 t 18.6 t 22.9 t 22.5 t
24 126.2 d 126.0 d 126.3 d 126.0 d 45.7 t 126.2 d 125.9 d
25 130.7 s 130.7 s 130.7 s 130.7 s 69.7 s 130.7 s 130.7 s
26 25.7 q 25.8 q 25.8 q 25.8 q 30.1 q 25.7 q 25.7 q
27 17.6 q 17.6 q 17.6 q 17.6 q 17.6 q 17.6 q 17.6 q
28 31.6 q 31.7 q 32.1 q 32.1 q 31.7 q 31.9 q 32.0 q
29 16.3 q 16.3 q 16.8 q 17.2 q 16.8 q 17.4 q 17.5 q
30 16.7 q 17.0 q 17.1 q 17.1 q 17.0 q 16.9 q 17.0 q
6-O-α-L-Rhamnopyranosyl
1′ 106.0 d 106.0 d 101.9 d 101.9 d 105.9 d 101.2 d 101.2 d
2′ 75.4 d 75.4 d 79.4 d 79.4 d 75.4 d 78.2 d 78.2 d
3′ 79.6 d 79.6 d 78.5 d 78.5 d 79.6 d 79.0 d 79.0 d
4′ 71.8 d 71.8 d 72.4 d 72.4 d 71.8 d 72.3 d 72.3 d
5′ 78.1 d 78.1 d 78.3 d 78.3 d 78.1 d 75.3 d 75.3 d
6′a 63.0 t 63.0 t 63.0 t 63.1 t 64.8 t 64.8 t
2′-O-α-L-Rhamnopyranosyl
1′ 101.7 d 101.7 d 102.0 d 102.0 d
2′′ 72.2 d 72.2 d 73.3 d 72.2 d
3′′ 72.5 d 72.6 d 72.2 d 72.2 d
4′′ 74.1 d 74.1 d 74.0 d 74.0 d
5′′ 69.4 d 69.4 d 69.3 d 69.3 d
6′′ 18.7 q 18.7 q 18.6 q 18.6 q
COCH3 170.7 s 170.7 s
COCH3 20.8 q 20.8 q

Multiplicity of 13C-NMR data was determined by DEPT experiments

1)

13C-NMR data measured at 125 MHz

2)

13C-NMR data measured at 150 MHz

3)

20(S)-AcetylRg2; 6′-O-acetyl-20(S)-Rg2

4)

20(R)-AcetylRg2; 6′-O-acetyl-20(R)-Rg2

Table 5.

1H-NMR Spectroscopic Data for Compounds 17–21 in Pyridine-d5

No. Rk1 (17) Rh4 (18) 25-Hydroxy-Rh4 (19) Rg5 (20) Oleanolic acid 28-O-β-D-glu (21)
δH (J in Hz)
1a 1.49 (1H, m) 1.67 (1H, m) 1.68 (1H, m) 1.47 (1H, m) 1.50 (1H, m)
1b 0.74 (1H, m) 1.01 (1H, m) 1.03 (1H, m) 0.75 (1H, m) 0.97 (1H,m)
2a 2.18 (1H, m) 1.85 (1H, m) 1.88 (1H, m) 2.18 (1H, m) 1.80 (2H, m)
2b 1.80 (1H, m) 1.80 (1H, m) 1.82 (1H, m) 1.78 (1H, m)
3 3.27 (1H, dd, J = 4.3, 11.7) 3.49 (1H, dd, J = 4.7, 11.6) 3.50 (1H, dd, J = 11.6, 4.6) 3.27 (1H, dd, J = 4.3, 11.6) 3.42 (1H, dd, J = 5.2, 10.8)
5 0.67 (1H, d, J = 11.2) 1.40 (1H, m) 1.41 (1H, m) 0.67 (1H, d, J = 11.1) 0.83 (1H, m)
6a 1.47 (1H, m) 4.40 (1H, td, J = 3.2, 10.3) 4.41 (1H, td, J = 10.6, 2.8) 1.51 (1H, m) 1.51 (1H, m)
6b 1.36 (1H, m) 1.36 (1H, m) 1.34 (1H, m)
7a 1.47 (1H, m) 2.49 (1H, m) 2.51 (1H, dd, J = 12.7, 2.8) 1.43 (1H, m) 1.52 (1H, m)
7b 1.24 (1H, m) 1.92 (1H, m) 1.93 (1H, m) 1.21 (1H, m) 1.40 (1H, m)
9 2.80 (1H, m) 1.53 (1H, m) 1.55 (1H, m) 1.38 (1H, m) 1.64 (1H, m)
11a 1.91 (1H, m) 1.95 (1H, m) 1.56 (1H, m) 1.91 (1H, m) 2.08 (2H, m)
11b 1.40 (1H, m) 1.41 (1H, m) 1.46 (1H, m) 1.41 (1H, m) 5.44 (1H, m)
12 3.89 (1H, m) 3.88 (1H, m) 3.88 (1H, m) 3.90 (1H, m)
13 2.06 (1H, m) 2.71 (1H, m) 1.97 (1H, m) 2.77 (1H, m)
15a 1.45 (1H, m) 1.52 (1H, m) 1.71 (1H, m) 1.64 (1H, m) 2.35 (1H, m)
15b 1.06 (1H, m) 1.11 (1H, m) 1.18 (1H, m) 1.09 (1H, m) 1.16 (1H, m)
16a 2.06 (1H, m) 1.45 (2H, m) 1.46 (2H, m) 1.98 (1H, m) 2.36 (1H, m)
16b 1.57 (1H, m) 1.96 (1H, m) 2.72 (1H, m) 1.52 (1H, m) 1.92 (1H, m)
17 1.40 (1H, m) 1.20 (3H, s) 0.81 (3H, s) 1.98 (1H, m)
18 1.01 (3H, s) 1.01 (3H, s) 1.02 (3H, s) 1.01 (3H, s) 3.19 (1H, dd, J = 2.8, 10.8)
19a 0.80 (3H, s) 0.81 (3H, s) 1.74 (1H, m)
19b 1.27 (1H, m)
21a 5.14 (2H, s) 1.77 (3H, s) 1.79 (3H, s) 1.81 (3H, s) 1.33 (1H, m)
21b 1.05 (1H, m)
22a 2.48 (1H, m) 5.43 (1H, t, J = 7.0) 5.55 (1H, t, J = 6.7) 5.50 (1H, t, J = 6.6) 1.83 (1H, m)
22b 2.38 (1H, m) 1.74 (1H, m)
23 2.32 (1H, m) 2.72 (2H, m) 2.33 (2H, m) 2.77 (2H, m) 1.22 (3H, s)
24 5.28 (1H, m) 5.18 (1H, m) 1.71 (2H, m) 5.22 (1H, t, J = 7.2) 1.01 (3H, s)
25 0.87 (3H, s)
26 1.66 (3H, s) 1.59 (3H, s) 1.33 (3H, s) 1.62 (3H, s) 1.12 (3H, s)
27 1.59 (3H, s) 1.56 (3H, s) 1.33 (3H, s) 1.58 (3H, s) 1.21 (3H, s)
28 1.27 (3H, s) 2.02 (3H, s) 2.04 (3H, s) 1.28 (3H, s)
29 1.09 (3H, s) 1.55 (3H, s) 1.58 (3H, s) 1.10 (3H, s) 0.91 (3H, s)
30 0.95 (3H, s) 0.80 (3H, s) 1.22 (3H, s) 0.95 (3H, s) 0.89 (3H, s)
3-O-β-D-Glucopyranosyl 6-O-β-D-Glucopyranosyl 6-O-β-D-Glucopyranosyl 6-O-β-D-Glucopyranosyl 28-O-β-D-Glucopyranosyl
1′ 4.89 (1H, m) 4.98 (1H, m) 5.01 (1H, d, J = 7.8) 4.91 (1H, d, J = 7.5) 6.31 (1H, d, J = 8.1)
2′ 4.20 (1H, m) 4.04 (1H, m) 4.06 (1H, m) 4.22 (1H, m) 4.18 (1H, m)
3′ 4.21 (1H, m) 4.20 (1H, m) 4.23 (1H, m) 4.23 (1H, m) 4.01 (1H, m)
4′ 4.11 (1H, m) 4.16 (1H, m) 4.19 (1H, m) 4.13 (1H, m) 4.33 (1H, m)
5′ 3.89 (1H, m) 3.91 (1H, m) 3.92 (1H, m) 3.90 (1H, m) 4.26 (1H, m)
6′a 4.53 (1H, m) 4.48 (1H, dd, J = 2.6, 11.6) 4.51 (1H, dd, J = 11.5, 2.5) 4.55 (1H, dd, J = 2.0, 11.7) 4.45 (1H, m)
6′b 4.32 (1H, m) 4.32 (1H, dd, J = 5.4, 11.6) 4.33 (1H, dd, J = 11.5, 5.4) 4.32 (1H, m) 4.37 (1H, m)
2′-O-β-D-Glucopyranosyl 2′-O-β-D-Glucopyranosyl
1′′ 5.33 (1H, d, J = 7.6) 5.35 (1H, d, J = 7.6)
2′′ 4.09 (1H, m) 4.12 (1H, m)
3′′ 4.28 (1H, m) 4.32 (1H, m)
4′′ 4.28 (1H, m) 4.30 (1H, m)
5′′ 3.89 (1H, m) 3.90 (1H, m)
6′′a 4.47 (1H, m) 4.46 (2H, m)
6′′b 4.43 (1H, m)

1H-NMR data measured at 500 MHz

Table 6.

13C-NMR Spectroscopic Data for Compounds 17–21 in Pyridine-d5

No. Rk1 (17) Rh4 (18) 25-hydroxy-Rh4 (19) Rg5 (20) Oleanolic acid 28-O-β-D-glucopyranoside (21)
δC multiplicity
1 39.3 t 39.4 t 39.5 t 39.3 t 39.0 t
2 26.7 t 28.7 t 27.9 t 26.7 t 28.1 t
3 88.9 d 78.5 d 78.5 d 88.9 d 78.1 d
4 39.7 s 40.3 s 40.3 s 40.2 s 39.4 s
5 56.4 d 61.4 d 61.4 d 56.4 d 55.8 d
6 18.4 t 80.0 d 80.0 d 18.4 t 18.8 t
7 35.3 t 45.2 t 45.3 t 35.3 t 33.1 t
8 40.2 s 41.3 s 41.3 s 39.7 s 40.0 s
9 48.2 d 50.5 d 50.5 d 50.8 d 48.1 d
10 37.0 s 39.7 s 39.7 s 37.0 s 37.4 s
11 32.6 t 32.2 t 32.2 t 32.2 t 23.4 t
12 72.4 d 72.5 d 72.6 d 72.6 d 122.9 d
13 52.4 d 50.3 d 50.8 d 50.4 d 144.1 s
14 51.2 s 50.6 s 50.6 s 50.9 s 42.1 s
15 32.6 t 32.5 t 32.5 t 32.6 t 28.3 t
16 30.7 t 27.8 t 28.7 t 28.1 t 23.6 t
17 50.8 d 50.7 d 50.5 d 51.0 d 47.0 s
18 15.8 q 17.3 q 16.8 q 15.8 q 41.8 d
19 16.4 q 17.6 q 17.7 q 16.6 q 46.2 t
20 155.5 s 140.0 s 139.5 s 140.2 s 30.8 s
21 108.1 t 13.0 q 13.0 q 13.1 q 34.0 t
22 33.8 t 123.5 d 125.5 d 123.2 d 32.5 t
23 27.0 t 27.4 t 23.6 t 27.4 t 28.8 q
24 125.3 d 123.8 d 44.2 t 123.5 d 16.5 q
25 131.2 s 131.2 s 69.5 s 131.2 s 15.6 q
26 25.7 q 25.6 q 29.9 q 25.7 q 17.5 q
27 17.7 q 17.6 q 29.7 q 17.7 q 26.1 q
28 28.1 q 31.6 q 31.7 q 28.8 q 176.4 s
29 16.5 q 16.3 q 16.3 q 16.4 q 33.2 q
30 17.0 q 16.7 q 17.4 q 17.0 q 23.8 q
3-O-β-D-Glucopyranosyl 6-O-β-D-Glucopyranosyl 6-O-β-D-Glucopyranosyl 6-O-β-D-Glucopyranosyl 28-O-β-D-Glucopyranosyl
1′ 105.1 d 105.9 d 106.0 d 105.1 d 95.7 d
2′ 83.4 d 75.3 d 75.4 d 83.4 d 74.1 d
3′ 77.9 d 79.5 d 79.6 d 78.2 d 79.3 d
4′ 71.6 d 71.7 d 71.8 d 71.6 d 71.1 d
5′ 78.2 d 78.0 d 78.1 d 77.9 d 78.9 d
6′ 62.8 t 63.0 t 63.1 t 62.7 t 62.2 t
2′-O-β-D-Glucopyranosyl 2′-O-β-D-Glucopyranosyl
1′′ 106.0 d 106.0 d
2′′ 77.0 d 77.1 d
3′′ 78.3 d 78.3 d
4′′ 71.6 d 71.7 d
5′′ 78.0 d 78.1 d
6′′ 62.7 t 62.8 t

Multiplicity of 13C NMR data was determined by DEPT experiments

13C-NMR data measured at 125 MHz

The comprehensive 1H-NMR and 13C-NMR spectral data of compounds 121 are worth determining for the structures of the less polar ginsenosides as some of their 1H-NMR and 13C-NMR spectroscopic data are not available. Other data are either scattered throughout published papers, or dated, therefore it is hard to compare the structures of the isolated compounds. In the study, the results were assigned using one-dimensional and two-dimensional NMR spectroscopic methods and were also confirmed by comparison with previously published data. Some signals, such as those for the methyl groups of C-26–C-30 and the saturated methylenes, which have not been reported previously, were unambiguously determined using two-dimensional NMR spectra including 1H-1H COSY, HSQC and HMBC spectra.

The 13C-NMR spectral data suggested the following information for the structural elucidation of the ginsenosides isomers. First, the chemical shifts of the characteristic peaks between the 20(S) and 20(R) ginsenosides provided information for the identification of the stereoisomers. In particular, changes in the chemical shifts between the S- and R- forms at C-17, C-21 and C-22 in the 13C-NMR spectra were approximately Δδ (δS – δR) +4.1 ± 0.1, +4.3 ± 0.1, and −7.4 ± 0.1 ppm, respectively (Tables 2 and 4). Next, the presence of the signal (δC 88.8 ± 0.1 ppm) of the hydroxyl carbon at C-3, which did not overlap with other hydroxyl groups in the backbone and the sugar moieties, easily indicated whether it was a PPD- (1–8, 17, and 20) or PPT-type (916 and 18). In addition, the signals at δC 170.6 ± 0.1 showed the existence of the acetyl groups (5, 6, 15, and 16) (Tables 2 and 4). It was assumed that they were produced from the malonyl moiety by decarboxylation during the manufacturing process and were located at C-6 in the glucose group (5, 6, 15, and 16) [23]. Finally, the chemical shifts of the down-field signals indicated the type of backbones. The values for a double bond at Δ24(25) in 3,12,20-trihydroxydammar-24-ene and 3,6,12,20-tetrahydroxydammar-24-ene (16, 9–12, 15, and 16) were δC 126.1 ± 0.2 (C-24) and 130.1 ± 0.1 (C-25), respectively (Tables 2 and 4). However, they were shifted to δC 124.2 ± 1.0 and 131.2 ± 0.0 as a result of the dehydration at Δ20(21) (17) or Δ20(22) (18 and 20) (Table 6). The differences between the chemical shifts of δC 155.5 and 108.1, and of δC 140.1 ± 0.1 and 123.4 ± 0.2 ppm indicated the discrimination of 3,12-dihydroxydammar-20, 24-diene (17) and 3,12-dihydroxydammar-20(22),24-diene (18 and 20). These results were in perfect agreement with previously published values [21,24,25]. Compound 21, an oleanane-type triterpene, might be produced by the selective hydrolysis of sugar residues at C-3 in ginsenoside Ro [26] (Table 6).

Conflicts of interest

All the contributing authors declare no conflicts of interest.

Acknowledgments

This research was supported equally by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2012R1A1A2039102), and the Global Leading Technology Program of the Office of Strategic R&D Planning (OSP grant 10039320), funded by the Ministry of Knowledge Economy, Korea.

Footnotes

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

  • 1.Jia L., Zhao Y., Liang X.J. Current evaluation of the millennium phytomedicine-ginseng (II): collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine. Curr Med Chem. 2009;16:2924–2942. doi: 10.2174/092986709788803204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Popovich D.G., Yeo C.R., Zhang W. Ginsenosides derived from Asian (Panax ginseng), American ginseng (Panax quinquefolius) and potential cytoactivity. Int J Biomed Pharm Sci. 2011;6:56–62. [Google Scholar]
  • 3.Lee S.M., Shon H.J., Choi C.S., Hung T.M., Min B.S., Bae K. Ginsenosides from heat processed ginseng. Chem Pharm Bull (Tokyo) 2009;57:92–94. doi: 10.1248/cpb.57.92. [DOI] [PubMed] [Google Scholar]
  • 4.Yoon S.R., Lee G.D., Park J.H., Lee I.S., Kwon J.H. Ginsenoside composition and antiproliferative activities of explosively puffed ginseng (Panax ginseng C.A. Meyer) J Food Sci. 2010;75:C378–C382. doi: 10.1111/j.1750-3841.2010.01592.x. [DOI] [PubMed] [Google Scholar]
  • 5.Park C.S., Yoo M.H., Noh K.H., Oh D.K. Biotransformation of ginsenosides by hydrolyzing the sugar moieties of ginsenosides using microbial glycosidases. Appl Microbiol Biotechnol. 2010;87:9–19. doi: 10.1007/s00253-010-2567-6. [DOI] [PubMed] [Google Scholar]
  • 6.Kim W.Y., Kim J.M., Han S.B., Lee S.K., Kim N.D., Park M.K., Kim C.K., Park J.H. Steaming of ginseng at high temperature enhances biological activity. J Nat Prod. 2000;63:1702–1704. doi: 10.1021/np990152b. [DOI] [PubMed] [Google Scholar]
  • 7.Sun B.S., Xu M.Y., Li Z., Wang Y.B., Sung C.K. UPLC-Q-TOF-MS/MS Analysis for steaming times-dependent profiling of steamed Panax quinquefolius and its ginsenosides transformations induced by repetitious steaming. J Ginseng Res. 2012;36:277–290. doi: 10.5142/jgr.2012.36.3.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Kang K.S., Kim H.Y., Baek S.H., Yoo H.H., Park J.H., Yokozawa T. Study on the hydroxyl radical scavenging activity changes of ginseng and ginsenoside-Rb2 by heat processing. Biol Pharm Bull. 2007;30:724–728. doi: 10.1248/bpb.30.724. [DOI] [PubMed] [Google Scholar]
  • 9.Zhan X., Song F.R., Cui M., Liu Z.Q., Liu S.Y. Investigation of the hydrolysis of ginsenosides by high performance liquid chromatography-electrospray ionization mass spectrometry. Planta Med. 2007;73:1225–1229. doi: 10.1055/s-2007-981590. [DOI] [PubMed] [Google Scholar]
  • 10.Park I.H., Han S.B., Kim J.M., Piao L.Z., Kwon S.W., Kim N.Y., Kang T.L., Park M.K., Park J.H. Four new acetylated ginsenosides from processed ginseng (sun ginseng) Arch Pharm Res. 2002;25:837–841. doi: 10.1007/BF02977001. [DOI] [PubMed] [Google Scholar]
  • 11.Zhang H.M., Li S.L., Zhang H., Wang Y., Zhao Z.L., Chen S.L., Xu H.X. Holistic quality evaluation of commercial white and red ginseng using a UPLC-QTOF-MS/MS-based metabolomics approach. J Pharm Biomed Anal. 2012;62:258–273. doi: 10.1016/j.jpba.2012.01.010. [DOI] [PubMed] [Google Scholar]
  • 12.Qi L.W., Wang C.Z., Yuan C.S. American ginseng: potential structure-function relationship in cancer chemoprevention. Biochem Pharmacol. 2010;80:947–954. doi: 10.1016/j.bcp.2010.06.023. [DOI] [PubMed] [Google Scholar]
  • 13.Yang H., Yoo G., Kim H.S., Kim J.Y., Kim S.O., Yoo Y.H., Sung S.H. Implication of the stereoisomers of ginsenoside derivatives in the antiproliferative effect of HSC-T6 cells. J Agri Food Chem. 2012;60:11759–11764. doi: 10.1021/jf303714c. [DOI] [PubMed] [Google Scholar]
  • 14.Wang W., Zhao Y.Q., Rayburn E.R., Hill D.L., Wang H., Zhang R.W. In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother Pharm. 2007;59:589–601. doi: 10.1007/s00280-006-0300-z. [DOI] [PubMed] [Google Scholar]
  • 15.Baek N., Kim D.S., Lee Y.H., Park J.D., Jeong S.Y., Lee C.B., Kim S.I. Complete assignment of 1H and 13C-NMR signals for (20S) and (20R)-protopanaxadiol by 2D-NMR techniques. Korean J Ginseng Sci. 1995;19:45–50. [Google Scholar]
  • 16.Teng R.W., Ang C., McManus D., Armstrong D., Mau S., Bacic A. Regioselective acylation of ginsenosides by Novozyme 435 to generate molecular diversity. Helv Chim Acta. 2004;87:1860–1872. [Google Scholar]
  • 17.Teng R.W., Li H.Z., Chen J.T., Wang D.Z., He Y.N., Yang C.R. Complete assignment of H-1 and C-13 NMR data for nine protopanaxatriol glycosides. Magn Reson Chem. 2002;40:483–488. [Google Scholar]
  • 18.Liao P.Y., Wang D., Zhang Y.J., Yang C.R. Dammarane-type glycosides from steamed notoginseng. J Agri Food Chem. 2008;56:1751–1756. doi: 10.1021/jf073000s. [DOI] [PubMed] [Google Scholar]
  • 19.Chen G., Yang M., Lu Z., Zhang J., Huang H., Liang Y., Guan S., Song Y., Wu L., Guo D.A. Microbial transformation of 20(S)-protopanaxatriol-type saponins by Absidia coerulea. J Nat Prod. 2007;70:1203–1206. doi: 10.1021/np070053v. [DOI] [PubMed] [Google Scholar]
  • 20.Jia J.M., Wang Z.Q., Wu L.J. Two new acetylated ginsenosides from the roots of Panax quinquefolium. Chinese Chem Lett. 2008;19:1099–1102. [Google Scholar]
  • 21.Liu J.W., Tian S.J., de Barry J., Luu B. Panaxadiol glycosides that induce neuronal differentiation in neurosphere stem cells. J Nat Prod. 2007;70:1329–1334. doi: 10.1021/np070135j. [DOI] [PubMed] [Google Scholar]
  • 22.Yin M., Wang X.Y., Wang M., Chen Y., Dong Y.F., Zhao Y.Y., Feng X. A new triterpenoid saponin and other saponins from Salicornia europaea. Chem Nat Compd. 2012;48:258–261. [Google Scholar]
  • 23.Li S.L., Lai S.F., Song J.Z., Qiao C.F., Liu X., Zhou Y., Cai H., Cai B.C., Xu H.X. Decocting-induced chemical transformations and global quality of Du-Shen-Tang, the decoction of ginseng evaluated by UPLC-Q-TOF-MS/MS based chemical profiling approach. J Pharm Biomed Anal. 2010;53:946–957. doi: 10.1016/j.jpba.2010.07.001. [DOI] [PubMed] [Google Scholar]
  • 24.Wu L.J., Wang L.B., Gao H.Y., Wu B., Song X.M., Tang Z.S. A new compound from the leaves of Panax ginseng. Fitoterapia. 2007;78:556–560. doi: 10.1016/j.fitote.2007.06.002. [DOI] [PubMed] [Google Scholar]
  • 25.Teng R.W., Li H.Z., Wang D.Z., Yang C.R. Hydrolytic reaction of plant extracts to generate molecular diversity: new dammarane glycosides from the mild acid hydrolysate of root saponins of Panax notoginseng. Helv Chim Acta. 2004;87:1270–1278. [Google Scholar]
  • 26.Wan J.-Y., Liu P., Wang H.-Y., Qi L.-W., Wang C.-Z., Li P., Yuan C.-S. Biotransformation and metabolic profile of American ginseng saponins with human intestinal microflora by liquid chromatography quadrupole time-of-flight mass spectrometry. J Chromatogr A. 2013;1286:83–92. doi: 10.1016/j.chroma.2013.02.053. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Ginseng Research are provided here courtesy of Elsevier

RESOURCES